306 related articles for article (PubMed ID: 15848316)
1. Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells.
Schmidt D; Mol A; Neuenschwander S; Breymann C; Gössi M; Zund G; Turina M; Hoerstrup SP
Eur J Cardiothorac Surg; 2005 May; 27(5):795-800. PubMed ID: 15848316
[TBL] [Abstract][Full Text] [Related]
2. Engineered living blood vessels: functional endothelia generated from human umbilical cord-derived progenitors.
Schmidt D; Asmis LM; Odermatt B; Kelm J; Breymann C; Gössi M; Genoni M; Zund G; Hoerstrup SP
Ann Thorac Surg; 2006 Oct; 82(4):1465-71; discussion 1471. PubMed ID: 16996955
[TBL] [Abstract][Full Text] [Related]
3. Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts.
Schmidt D; Breymann C; Weber A; Guenter CI; Neuenschwander S; Zund G; Turina M; Hoerstrup SP
Ann Thorac Surg; 2004 Dec; 78(6):2094-8. PubMed ID: 15561042
[TBL] [Abstract][Full Text] [Related]
4. Construction of tissue-engineered heart valves by using decellularized scaffolds and endothelial progenitor cells.
Fang NT; Xie SZ; Wang SM; Gao HY; Wu CG; Pan LF
Chin Med J (Engl); 2007 Apr; 120(8):696-702. PubMed ID: 17517187
[TBL] [Abstract][Full Text] [Related]
5. Tissue engineering of autologous human heart valves using cryopreserved vascular umbilical cord cells.
Sodian R; Lueders C; Kraemer L; Kuebler W; Shakibaei M; Reichart B; Daebritz S; Hetzer R
Ann Thorac Surg; 2006 Jun; 81(6):2207-16. PubMed ID: 16731156
[TBL] [Abstract][Full Text] [Related]
6. Human umbilical cord cells for cardiovascular tissue engineering: a comparative study.
Kadner A; Zund G; Maurus C; Breymann C; Yakarisik S; Kadner G; Turina M; Hoerstrup SP
Eur J Cardiothorac Surg; 2004 Apr; 25(4):635-41. PubMed ID: 15037283
[TBL] [Abstract][Full Text] [Related]
7. Living autologous heart valves engineered from human prenatally harvested progenitors.
Schmidt D; Mol A; Breymann C; Achermann J; Odermatt B; Gössi M; Neuenschwander S; Prêtre R; Genoni M; Zund G; Hoerstrup SP
Circulation; 2006 Jul; 114(1 Suppl):I125-31. PubMed ID: 16820561
[TBL] [Abstract][Full Text] [Related]
8. Human umbilical cord-derived endothelial progenitor cells promote growth cytokines-mediated neorevascularization in rat myocardial infarction.
Hu CH; Li ZM; DU ZM; Zhang AX; Yang DY; Wu GF
Chin Med J (Engl); 2009 Mar; 122(5):548-55. PubMed ID: 19323906
[TBL] [Abstract][Full Text] [Related]
9. In vitro fabrication of a tissue engineered human cardiovascular patch for future use in cardiovascular surgery.
Yang C; Sodian R; Fu P; Lüders C; Lemke T; Du J; Hübler M; Weng Y; Meyer R; Hetzer R
Ann Thorac Surg; 2006 Jan; 81(1):57-63. PubMed ID: 16368335
[TBL] [Abstract][Full Text] [Related]
10. Healing and remodeling of bioengineered pulmonary artery patches implanted in sheep.
Mendelson K; Aikawa E; Mettler BA; Sales V; Martin D; Mayer JE; Schoen FJ
Cardiovasc Pathol; 2007; 16(5):277-82. PubMed ID: 17868878
[TBL] [Abstract][Full Text] [Related]
11. Prenatally fabricated autologous human living heart valves based on amniotic fluid derived progenitor cells as single cell source.
Schmidt D; Achermann J; Odermatt B; Breymann C; Mol A; Genoni M; Zund G; Hoerstrup SP
Circulation; 2007 Sep; 116(11 Suppl):I64-70. PubMed ID: 17846327
[TBL] [Abstract][Full Text] [Related]
12. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
[TBL] [Abstract][Full Text] [Related]
13. Prenatally harvested cells for cardiovascular tissue engineering: fabrication of autologous implants prior to birth.
Weber B; Zeisberger SM; Hoerstrup SP
Placenta; 2011 Oct; 32 Suppl 4():S316-9. PubMed ID: 21575988
[TBL] [Abstract][Full Text] [Related]
14. Direct comparison of umbilical cord blood versus bone marrow-derived endothelial precursor cells in mediating neovascularization in response to vascular ischemia.
Finney MR; Greco NJ; Haynesworth SE; Martin JM; Hedrick DP; Swan JZ; Winter DG; Kadereit S; Joseph ME; Fu P; Pompili VJ; Laughlin MJ
Biol Blood Marrow Transplant; 2006 May; 12(5):585-93. PubMed ID: 16635794
[TBL] [Abstract][Full Text] [Related]
15. Preliminary experience with tissue engineering of a venous vascular patch by using bone marrow-derived cells and a hybrid biodegradable polymer scaffold.
Cho SW; Jeon O; Lim JE; Gwak SJ; Kim SS; Choi CY; Kim DI; Kim BS
J Vasc Surg; 2006 Dec; 44(6):1329-40. PubMed ID: 17145438
[TBL] [Abstract][Full Text] [Related]
16. Toward engineering a human neoendothelium with circulating progenitor cells.
Allen JB; Khan S; Lapidos KA; Ameer GA
Stem Cells; 2010 Feb; 28(2):318-28. PubMed ID: 20013827
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells.
Wu KH; Zhou B; Lu SH; Feng B; Yang SG; Du WT; Gu DS; Han ZC; Liu YL
J Cell Biochem; 2007 Feb; 100(3):608-16. PubMed ID: 16960877
[TBL] [Abstract][Full Text] [Related]
18. Vascular patches tissue-engineered with autologous bone marrow-derived cells and decellularized tissue matrices.
Cho SW; Park HJ; Ryu JH; Kim SH; Kim YH; Choi CY; Lee MJ; Kim JS; Jang IS; Kim DI; Kim BS
Biomaterials; 2005 May; 26(14):1915-24. PubMed ID: 15576165
[TBL] [Abstract][Full Text] [Related]
19. Construction of an autologous tissue-engineered venous conduit from bone marrow-derived vascular cells: optimization of cell harvest and seeding techniques.
Roh JD; Brennan MP; Lopez-Soler RI; Fong PM; Goyal A; Dardik A; Breuer CK
J Pediatr Surg; 2007 Jan; 42(1):198-202. PubMed ID: 17208565
[TBL] [Abstract][Full Text] [Related]
20. Development of anti-atherosclerotic tissue-engineered blood vessel by A20-regulated endothelial progenitor cells seeding decellularized vascular matrix.
Zhu C; Ying D; Mi J; Li L; Zeng W; Hou C; Sun J; Yuan W; Wen C; Zhang W
Biomaterials; 2008 Jun; 29(17):2628-36. PubMed ID: 18377984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
